Nicotinell

Nicotine, the active ingredient in Nicotinell, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adults.\n\nGNH India supplies Nicotinell as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotinell is a nicotine replacement therapy used to support smoking cessation.\n\n- Smoking cessation: provides a steady dose of nicotine to reduce withdrawal symptoms and increase quit rates.\n- Tobacco dependence: delivers controlled nicotine to help adults transition away from cigarettes.\n- Relapse prevention: maintains low nicotine levels to discourage return to smoking after initial cessation.

Common side effects are generally mild and related to the patch site or systemic nicotine exposure.\n\nCommon Side Effects:\n- Skin irritation: redness, itching or rash at the application site.\n- Sleep disturbance: difficulty falling asleep or staying asleep.\n- Vivid dreams or nightmares.\n- Nausea or mild gastrointestinal upset.\n\nSerious or Rare Side Effects:\n- Allergic reaction: swelling, hives or difficulty breathing.\n- Severe skin reaction: blistering or extensive dermatitis.\n- Cardiovascular events: rapid heart rate, hypertension or chest pain.

Before using Nicotinell, consider the following safety measures.\n\n- Cardiovascular assessment: evaluate history of heart disease or recent myocardial infarction.\n- Hypertension monitoring: use with caution in patients with high blood pressure.\n- Pregnancy and lactation: avoid unless specifically advised by a healthcare professional.\n- Pediatric use: not recommended for children or adolescents.\n- Storage: Store at room temperature: keep in the original pouch, protect from moisture and direct heat.

Nicotinell may interact with other substances that affect nicotine levels or cardiovascular function.\n\nMajor Interactions (Avoid):\n- Concurrent nicotine products: risk of nicotine overdose.\n- Monoamine oxidase inhibitors: may enhance nicotine’s sympathomimetic effects.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: nicotine‑induced tachycardia may be masked.\n- Warfarin: nicotine can alter metabolism, affecting INR.\n- Insulin or oral hypoglycemics: nicotine may affect blood glucose control.\n- Caffeine‑containing products: may increase stimulation and jitteriness.